Improving Noninvasive Colorectal Cancer Screening.
作者信息
Carethers John M
机构信息
From the Division of Gastroenterology and Hepatology, Department of Medicine, Moores Cancer Center, and the Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, San Diego.
出版信息
N Engl J Med. 2024 Mar 14;390(11):1045-1046. doi: 10.1056/NEJMe2400366.
Abstract
摘要
相似文献
1
Improving Noninvasive Colorectal Cancer Screening.改善非侵入性结直肠癌筛查
N Engl J Med. 2024 Mar 14;390(11):1045-1046. doi: 10.1056/NEJMe2400366.
2
Overview of colorectal cancer screening.结直肠癌筛查概述。
Colorectal Dis. 2019 Mar;21 Suppl 1:14-15. doi: 10.1111/codi.14487.
3
Colorectal Cancer Screening Challenges in West Virginia.西弗吉尼亚州的结直肠癌筛查挑战
W V Med J. 2015 Nov-Dec;111(6):12-3.
4
Screening for cancer.癌症筛查
Int J Cancer. 2010 Mar 1;126(5):1037-8. doi: 10.1002/ijc.25092.
5
Breath analysis for colorectal cancer screening.用于结直肠癌筛查的呼吸分析
Colorectal Dis. 2016 Dec;18(12):1127-1128. doi: 10.1111/codi.13480.
6
Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.结直肠癌筛查：粪便DNA及其他非侵入性检查方法
Gut Liver. 2016 Mar;10(2):204-11. doi: 10.5009/gnl15420.
7
Colorectal cancer screening.结直肠癌筛查
Br J Surg. 2014 Oct;101(11):1338-40. doi: 10.1002/bjs.9599. Epub 2014 Aug 4.
8
Where does it FIT? The roles of fecal testing and colonoscopy in colorectal cancer screening.它适用于何处？粪便检测和结肠镜检查在结直肠癌筛查中的作用。
Cancer. 2015 Sep 15;121(18):3186-9. doi: 10.1002/cncr.29459. Epub 2015 May 20.
9
Screening for colorectal cancer in Taiwan and France: Does the fecal immunochemical test (FIT) fit?台湾和法国的结直肠癌筛查：粪便免疫化学检测（FIT）适用吗？
Cancer. 2015 Dec 15;121(24):4441-2. doi: 10.1002/cncr.29657. Epub 2015 Sep 8.
10
[Necessity and feasibility of screening for colorectal cancer in China].[中国结直肠癌筛查的必要性与可行性]
Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Jan;14(1):16-8.
引用本文的文献
1
Cancer Screening Progress and Noninvasive Screening Opportunities since the Onset of the COVID-19 Pandemic.自新冠疫情爆发以来的癌症筛查进展与非侵入性筛查机遇
Cancer Prev Res (Phila). 2025 Jun 2;18(6):313-319. doi: 10.1158/1940-6207.CAPR-25-0007.
2
The Potential of a Cell-Free DNA Methylation-Based Blood Test in Colorectal Cancer Screening.基于游离DNA甲基化的血液检测在结直肠癌筛查中的潜力
Mol Diagn Ther. 2025 May 6. doi: 10.1007/s40291-025-00783-9.
3
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.粪便和血液生物标志物在结直肠癌管理中的应用：筛查和疾病监测的最新进展。
Mol Cancer. 2024 Nov 19;23(1):259. doi: 10.1186/s12943-024-02174-w.
4
Genomic-Based Early Detection Screening: A Literature Review of Prospective Trials and Emerging Strategies for Gastrointestinal Cancers.基于基因组的早期检测筛查：胃肠道癌症前瞻性试验及新兴策略的文献综述
Cureus. 2024 Sep 7;16(9):e68881. doi: 10.7759/cureus.68881. eCollection 2024 Sep.
5
Pioneering colorectal cancer screening: blood-based DNA tests as a global strategy for early detection - editorial.开创性的结直肠癌筛查：基于血液的DNA检测作为早期检测的全球策略——社论
Int J Surg. 2024 Nov 1;110(11):6906-6910. doi: 10.1097/JS9.0000000000001964.
本文引用的文献
1
Cell-free DNA for Colorectal Cancer Screening.用于结直肠癌筛查的游离DNA
N Engl J Med. 2024 Mar 14;390(11):1047-1050. doi: 10.1056/NEJMe2311101.
2
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.用于结直肠癌筛查的下一代多靶点粪便 DNA 检测。
N Engl J Med. 2024 Mar 14;390(11):984-993. doi: 10.1056/NEJMoa2310336.
3
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
4
Multitarget Stool RNA Test for Colorectal Cancer Screening.多靶点粪便 RNA 检测用于结直肠癌筛查。
JAMA. 2023 Nov 14;330(18):1760-1768. doi: 10.1001/jama.2023.22231.
5
Stool-Based Screening Tests for Colorectal Cancer.基于粪便的结直肠癌筛查测试
JAMA. 2023 Mar 14;329(10):839-840. doi: 10.1001/jama.2023.0547.
6
Commencing colorectal cancer screening at age 45 years in U.S. racial groups.在美国不同种族群体中从45岁开始进行结直肠癌筛查。
Front Oncol. 2022 Jul 22;12:966998. doi: 10.3389/fonc.2022.966998. eCollection 2022.
7
Association between Improved Colorectal Screening and Racial Disparities.改善的结直肠癌筛查与种族差异之间的关联。
N Engl J Med. 2022 Feb 24;386(8):796-798. doi: 10.1056/NEJMc2112409.
8
Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk.普通风险人群的结直肠癌筛查试验利用情况。
JAMA Netw Open. 2021 Sep 1;4(9):e2122269. doi: 10.1001/jamanetworkopen.2021.22269.
9
Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening.非裔美国人的结直肠癌筛查：开始筛查的年龄提前的决定因素及基本原理。
Dig Dis Sci. 2015 Mar;60(3):711-21. doi: 10.1007/s10620-014-3443-5. Epub 2014 Dec 25.
10
Multitarget stool DNA testing for colorectal-cancer screening.多靶点粪便 DNA 检测用于结直肠癌筛查。
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.
Zotero 插件